asquaredm led the financial and operational assessment about how to take best and appropriate advantage of CMS reimbursement guidelines regarding the Medicare 340B pharmaceutical program to resolve operational losses around their infusion program. Worked with both the academic hospital management and the academic practice plan to revise and restructure financial relationships, operations and physician compensation plans. Allowed hospital to improve their clinical operations related to infusion services, improve staff productivity, reduce cost and allow physician compensation to achieve Fair Market Value level of its region.